Medullary thyroid carcinoma surveillance study: A case series registry

Study identifier:D5551R00001

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Recruiting

Official Title

Medullary thyroid carcinoma surveillance study: A case series registry

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Estimated Enrollment

Study type

Observational

Age

Date

Study Start Date: 01 Jan 2012

Primary Completion Date: -

Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 May 2014 by UBC

Collaborators

AstraZeneca, Novo nordisk

Inclusion and exclusion criteria

Sort by status

No locations available

Arms	Assigned Interventions

Documents available

Trial Results Summaries
Available here

Medullary thyroid carcinoma surveillance study: A case series registry

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Estimated Enrollment

Study type

Age

Date

Study design

Verification:

Sponsors

Collaborators

Inclusion Criteria

Exclusion Criteria

Documents available

Trial Results Summaries